CANTA — Cantargia AB Share Price
0.000.00%
Last trade - 00:00- SEK684.78m
- SEK490.04m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.06 | ||
| Price to Tang. Book | 4.17 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -171.75% | ||
| Return on Equity | -100.29% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | 192.67 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cantargia AB is a Sweden-based company engaged in development of antibody therapeutics for the treatment of leukemia. The Company is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Cantargia AB uses the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia.
Directors
- Magnus Persson CHM (61)
- Goran Forsberg CEO (56)
- Bengt Jondell CFO (57)
- Liselotte Larsson COO (57)
- Susanne Lagerlund VPR
- David Liberg VPR (47)
- Nedjad Losic VPR (47)
- Peter Madsen VPR
- Lars Thorsson VPR (55)
- Ignacio Garcia-Ribas OTH
- Claus Andersson DRC (52)
- Patricia Delaite DRC (54)
- Thoas Fioretos DRC (54)
- Karin Leandersson DRC (44)
- Anders Martin-Lof DRC (49)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 26th, 2009
- Public Since
- March 17th, 2015
- No. of Employees
- 22
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 183,686,684
- Address
- Scheelevagen 27, LUND, 223 63
- Web
- https://cantargia.com/
- Phone
- +46 462756260
- Contact
- Goeran Forsberg
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for CANTA
Cantargia AB Annual Shareholders Meeting
Cantargia AB Annual Shareholders Meeting
Q2 2024 Cantargia AB Earnings Release
Similar to CANTA
2cureX AB
OMX Nordic Exchange Stockholm
Abliva AB
OMX Nordic Exchange Stockholm
Acousort AB
OMX Nordic Exchange Stockholm
Active Biotech AB publ
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
FAQ
What is the Cantargia AB share price?
As of Today at 19:04 UTC, shares in Cantargia AB are trading at SEK3.73. This share price information is delayed by 15 minutes.
How has the Cantargia AB share price performed this year?
Shares in Cantargia AB last closed at SEK3.73 and the price had moved by -44.19% over the past 365 days. In terms of relative price strength the Cantargia AB share price has underperformed the FTSE Global All Cap Index by -47.61% over the past year.
What are the analyst and broker recommendations for Cantargia AB?
The overall consensus recommendation for Cantargia AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Cantargia AB dividend yield?
Cantargia AB does not currently pay a dividend.
Does Cantargia AB pay a dividend?
Cantargia AB does not currently pay a dividend.
When does Cantargia AB next pay dividends?
Cantargia AB does not currently pay a dividend.
How do I buy Cantargia AB shares?
To buy shares in Cantargia AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cantargia AB?
As of the previous close price of SEK3.73, shares in Cantargia AB had a market capitalisation of SEK684.78m.
Where are Cantargia AB shares listed?
Here are the trading details for Cantargia AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: CANTA
What kind of share is Cantargia AB?
Based on an overall assessment of its quality, value and momentum Cantargia AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cantargia AB share price forecast for 2024?
The analyst consensus target price for shares in Cantargia AB is SEK11.05. That is 196.41% above the last closing price of SEK3.73.
Analysts covering Cantargia AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK1.53 for the next financial year.
What is the trend in the Cantargia AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cantargia AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -20.91%.
As of the last closing price of SEK3.73, shares in Cantargia AB were trading -2.5% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cantargia AB PE Ratio?
The Cantargia AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK3.73.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cantargia AB?
Cantargia AB's management team is headed by:
- Magnus Persson - CHM
- Goran Forsberg - CEO
- Bengt Jondell - CFO
- Liselotte Larsson - COO
- Susanne Lagerlund - VPR
- David Liberg - VPR
- Nedjad Losic - VPR
- Peter Madsen - VPR
- Lars Thorsson - VPR
- Ignacio Garcia-Ribas - OTH
- Claus Andersson - DRC
- Patricia Delaite - DRC
- Thoas Fioretos - DRC
- Karin Leandersson - DRC
- Anders Martin-Lof - DRC